Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Xeris Pharmaceuticals
Xeris Pharmaceuticals
(XERS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Keveyis
Dichlorphenamide
1982-01-01
Glaucoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Glucagon
healthy volunteers/patients
,
common cold
,
liver failure
,
hepatic insufficiency
,
chronic kidney failure
,
renal insufficiency
,
hyperglycemia
,
chronic renal insufficiency
,
overnutrition
,
binge-eating disorder
,
insulin resistance
,
alopecia
,
type 1 diabetes mellitus
,
hypoglycemia
,
glucose metabolism disorders
,
endocrine system diseases
,
weight loss
,
non-alcoholic fatty liver disease
,
fatty liver
,
nutrition disorders
,
left ventricular dysfunction
,
heart failure
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
prediabetic state
,
disease
,
motor activity
,
weight gain
,
ulcerative colitis
,
crohn disease
,
type 2 diabetes mellitus
,
obesity
,
diabetes mellitus
,
overweight
,
metabolic diseases
,
metabolic syndrome
,
body weight
,
psoriatic arthritis
,
coronary artery disease
,
psoriasis
,
myocardial ischemia
,
atherosclerosis
,
knee osteoarthritis
,
osteoarthritis
,
fasting
,
headache
,
pseudotumor cerebri
,
inflammatory bowel diseases
,
colonic pouches
,
carcinoma
,
thyroid neoplasms
,
neuroendocrine carcinoma
,
papillary thyroid cancer
,
thyroid diseases
,
diabetic nephropathies
,
inflammation
Bevifimod
basal cell carcinoma
,
basal cell neoplasms
,
actinic keratosis
Insulin
delayed puberty
,
duchenne muscular dystrophy
,
growth disorders
,
dwarfism
,
failure to thrive
,
laron syndrome
,
syndrome
,
insulin resistance
,
acromegaly
Viaject
breast neoplasms
,
overweight
,
sarcoma
,
diabetes mellitus
,
type 2 diabetes mellitus
,
insulin resistance
,
chronic hepatitis c
,
hepatitis
,
obesity
,
non-alcoholic fatty liver disease
,
fatty liver
,
type 1 diabetes mellitus
,
hepatitis c
,
hepatitis a
Pram9
type 1 diabetes mellitus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use